Queen Mary Hospital - Hong Kong

Hong Kong 0

1 studies enrolling now · 2 studies all time

What they study most

Adjuvant, Advanced Non-Small Cell Lung Cancer, EGFR, Early Stage Lung Cancer, Exon 20, Lung Cancer, Metastatic Non-Small Cell Lung Cancer, NSCLC, Stage IB-IIIA, Post-surgical, Uncommon EGFR Mutations

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling